Journal of Ginseng Research

The Korean Society of Ginseng (고려인삼학회)
권호 표지
DOI QR코드

DOI QR Code

Anti-breast cancer activity of Fine Black ginseng (Panax ginseng Meyer) and ginsenoside Rg5

  • Kim, Shin-Jung (College of Pharmacy, Sookmyung Women's University) ;
  • Kim, An Keun (College of Pharmacy, Sookmyung Women's University)
  • Received : 2014.07.08
  • Accepted : 2014.09.22
  • Published : 2015.04.15
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Black ginseng (Ginseng Radix nigra, BG) refers to the ginseng steamed for nine times and fine roots (hairy roots) of that is called fine black ginseng (FBG). It is known that the content of saponin of FBG is higher than that of BG. Therefore, in this study, we examined antitumor effects against MCF-7 breast cancer cells to target the FBG extract and its main component, ginsenoside Rg5 (Rg5). Methods: Action mechanism was determined by MTT assay, cell cycle assay and western blot analysis. Results: The results from MTT assay showed that MCF-7 cell proliferation was inhibited by Rg5 treatment for 24, 48 and 72 h in a dose-dependent manner. Rg5 at different concentrations (0, 25, 50 and $100{\mu}M$), induced cell cycle arrest in G0/G1 phase through regulation of cell cycle-related proteins in MCF-7 cells. As shown in the results from western blot analysis, Rg5 increased expression of p53, $p21^{WAF1/CIP1}$ and $p15^{INK4B}$ and decreased expression of Cyclin D1, Cyclin E2 and CDK4. Expression of apoptosiserelated proteins including Bax, PARP and Cytochrome c was also regulated by Rg5. These results indicate that Rg5 stimulated cell apoptosis and cell cycle arrest at G0/G1 phase via regulation of cell cycle-associated proteins in MCF-7 cells. Conclusion: Rg5 promotes breast cancer cell apoptosis in a multi-path manner with higher potency compared to 20(S)-ginsenoside Rg3 (Rg3) in MCF-7 (HER2/ER+) and MDA-MB-453 (HER2+/ER) human breast cancer cell lines, and this suggests that Rg5 might be an effective natural new material in improving breast cancer.

Keywords

References

  1. Namba T. The encyclopedia of Wakan-Yaku with color pictures. Osaka: Hoikusha; 1980.
  2. Park JD. Recent studies on the chemical constituents of Korean Ginseng (Panax ginseng C.A. Meyer). Korea J Ginseng Sci 1996;20:389-415.
  3. Yokozawa T, Kobayashi T, Oura H, Kawashima Y. Studies on the mechanism of the hypoglycemic activity of ginsenoside-Rb2 in streptozotocin-diabetic rats. Chem Pharm Bull (Tokyo) 1985;33:869-72. https://doi.org/10.1248/cpb.33.869
  4. Park SE, Park C, Kim SH, Hossain MA, Kim MY, Chung HY, Son WS, Kim GY, Choi YH, Kim ND. Korean Red Ginseng extract induces apoptosis and decreases telomerase activity in human leukemia cells. J Ethnopharmacol 2009;121:304-12. https://doi.org/10.1016/j.jep.2008.10.038
  5. Fukushima S, WanibuchiH LW. Inhibition by ginseng of colon carcinogenesis in rats. J Korean Med Sci 2001;16:75-80.
  6. Keum YS, Han SS, Chun KS, Park KK, Park JH, Lee SK, Surh YJ. Inhibitory effects of the ginsenoside Rg3 on phorbol ester-induced cyclooxygenase-2 expression, NF-kappaB activation and tumor promotion. Mutat Res 2003;523-524:75-85. https://doi.org/10.1016/S0027-5107(02)00323-8
  7. Kim ND, Kang SY, Park JH, Schini-Kerth VB. Ginsenoside Rg3 mediates endothelium-dependent relaxation in response to ginsenosides in rat aorta: role of K+ channels. Eur J Pharmacol 1999;367:41-9. https://doi.org/10.1016/S0014-2999(98)00898-X
  8. Keum YS, Park KK, Lee JM, Chun KS, Park JH, Lee SK, Kwon H, Surh YJ. Antioxidant and anti-tumor promoting activities of the methanol extract of heatprocessed ginseng. Cancer Lett 2000;150:41-8. https://doi.org/10.1016/S0304-3835(99)00369-9
  9. Helms S. Cancer prevention and therapeutics: Panax ginseng. Altern Med Rev 2004;9:259-74.
  10. Oh M, Choi YH, Choi S, Chung H, Kim K, Kim SI, Kim DK, Kim ND. Antiproliferating effects of ginsenoside Rh2 on MCF-7 human breast cancer cells. Int J Oncol 1999;14:869-75.
  11. Li B, Zhao J, Wang CZ, Searle J, He TC, Yuan CS, Du W. Ginsenoside Rh2 induces apoptosis and paraptosis-like cell death in colorectal cancer cells through activation of p53. Cancer Lett 2011;301:185-92. https://doi.org/10.1016/j.canlet.2010.11.015
  12. Choi S, Kim TW, Singh SV. Ginsenoside Rh2-mediated G1 phase cell cycle arrest in human breast cancer cells is caused by p15 Ink4B and p27 Kip1- dependent inhibition of cyclin-dependent kinases. Pharm Res 2009;26: 2280-8. https://doi.org/10.1007/s11095-009-9944-9
  13. Lee SA, Jo HK, Im BO, Kim S, Whang WK, Ko SK. Changes in the contents of prosapogenin in the Red Ginseng (Panax ginseng) depending on steaming batches. J Ginseng Res 2012;36:102-6. https://doi.org/10.5142/jgr.2012.36.1.102
  14. Lee YY, Park JS, Jung JS, Kim DH, Kim HS. Anti-inflammatory effect of ginsenoside Rg5 in lipopolysaccharide-stimulated BV2 microglial cells. Int J Mol Sci 2013;14:9820-33. https://doi.org/10.3390/ijms14059820
  15. Kim EJ, Jung IH, Van Le TK, Jeong JJ, Kim NJ, Kim DH. Ginsenosides Rg5 and Rh3 protect scopolamine-induced memory deficits in mice. J Ethnopharmacol 2013;146:294-9. https://doi.org/10.1016/j.jep.2012.12.047
  16. Shin YW, Bae EA, Kim DH. Inhibitory effect of ginsenoside Rg5 and its metabolite ginsenoside Rh3 in an oxazolone-induced mouse chronic dermatitis model. Arch Pharm Res 2006;29:685-90. https://doi.org/10.1007/BF02968253
  17. Lee KY, Lee YH, Kim SI, Park JH, Lee SK. Ginsenoside-Rg5 suppresses cyclin Edependent protein kinase activity via up-regulating p21Cip/WAF1 and downregulating cyclin E in SK-HEP-1 cells. Anticancer Res 1997;17:1067-72.
  18. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin 2014;64: 9-29. https://doi.org/10.3322/caac.21208
  19. Statistics Korea. 2012 Annual report on the cause of death statistics. In: Office KNS, editor. Daejeon, Korea: Statistics Korea; 2013.
  20. Lee JH, Shen GN, Kim EK, Shin HJ, Myung CS, Oh HJ, Kim DH, Roh SS, Cho W, Seo YB, et al. Preparation of black ginseng and its antitumor activity. Korean J Oriental Physiol Pathol 2006;20:951-6.
  21. Ko SK, Bae HM, Cho OS, Im BO, Chung SH, Lee BY. Analysis of ginsenoside composition of ginseng berry and seed. Food Sci Biotechnol 2008;17: 1379-82.
  22. Kim SI, Park JH, Ryu JH, Park JD, Lee YH, Kim TH, Baek NI. Ginsenoside Rg5, a genuine dammarane glycoside from Korean red ginseng. Arch Pharm Res 1996;19:551-3. https://doi.org/10.1007/BF02986026
  23. Han ST, Whang WK, Kim IH, Yang BW, Cho SH, Ko SK. Analysis of ginsenosides of Black Ginseng. Yakhak Hoeji 2005;49:490-4.
  24. Benhar M, Dalyot I, Engelberg D, Levitzki A. Enhanced ROS production in oncogenically transformed cells potentiates c-Jun N-terminal kinase and p38 mitogen-activated protein kinase activation and sensitization to genotoxic stress. Mol Cell Biol 2001;21:6913-26. https://doi.org/10.1128/MCB.21.20.6913-6926.2001
  25. Fukuda S, Pelus LM. Survivin, a cancer target with an emerging role in normal adult tissues. Mol Cancer Ther 2006;5:1087-98. https://doi.org/10.1158/1535-7163.MCT-05-0375
  26. Jo HK, Sung MC, Ko SK. The comparison of ginseng prosapogenin composition and contents in Red and Black ginseng. Kor J Pharmacogn 2011;42:361-5.
  27. Kang KS, Kim HY, Yamabe N, Yokozawa T. Stereospecificity in hydroxyl radical scavenging activities of four ginsenosides produced by heat processing. Bioorg Med Chem Lett 2006;16:5028-31. https://doi.org/10.1016/j.bmcl.2006.07.071
  28. Choi YJ, Lee HJ, Kang DW, Han IH, Choi BK, Cho WH. Ginsenoside Rg3 induces apoptosis in the U87MG human glioblastoma cell line through the MEK signaling pathway and reactive oxygen species. Oncol Rep 2013;30: 1362-70. https://doi.org/10.3892/or.2013.2555
  29. Song Y, Hou J, Kang L, Gao S. Effect of 20(S)-ginsenoside Rg3 on the proliferation inhibition and secretion of vascular endothelial growth factor of multiple myeloma cell line U266 [in Chinese]. Zhonghua Xue Ye Xue Za Zhi 2014;35:519-23.
  30. Kim JW, Jung SY, Kwon YH, Lee JH, Lee YM, Lee BY, Kwon SM. Ginsenoside Rg3 attenuates tumor angiogenesis via inhibiting bioactivities of endothelial progenitor cells. Cancer Biol Ther 2012;13:504-15. https://doi.org/10.4161/cbt.19599
  31. Park HM, Kim SJ, Kim JS, Kang HS. Reactive oxygen species mediated ginsenoside Rg3- and Rh2-induced apoptosis in hepatoma cells through mitochondrial signaling pathways. Food Chem Toxicol 2012;50:2736-41. https://doi.org/10.1016/j.fct.2012.05.027
  32. Pan XY, Guo H, Han J, Hao F, An Y, Xu Y, Xiaokaiti Y, Pan Y, Li XJ. Ginsenoside Rg3 attenuates cell migration via inhibition of aquaporin 1 expression in PC- 3M prostate cancer cells. Eur J Pharmacol 2012;683:27-34. https://doi.org/10.1016/j.ejphar.2012.02.040
  33. Yu Y, Zhang C, Liu L, Li X. Hepatic arterial administration of ginsenoside Rg3 and transcatheter arterial embolization for the treatment of VX2 liver carcinomas. Exp Ther Med 2013;5:761-6. https://doi.org/10.3892/etm.2012.873
  34. Guo XX, Li Y, Sun C, Jiang D, Lin YJ, Jin FX, Lee SK, Jin YH. p53-dependent Fas expression is critical for Ginsenoside Rh2 triggered caspase-8 activation in HeLa cells. Protein Cell 2014;5:224-34. https://doi.org/10.1007/s13238-014-0027-2
  35. Sheu MJ, Chou PY, Huang CS, Tsai IC, Chien YC, Lin SY, Tsai HY, Cheng HC, Wu CH. Pipoxolan inhibits proliferation of HL-60 human leukaemia cancer cells by arresting the cell cycle at the G0/G1 phase. Clin Exp Pharmacol Physiol 2010;37:605-12. https://doi.org/10.1111/j.1440-1681.2010.05358.x
  36. Morrison RS, Wenzel HJ, Kinoshita Y, Robbins CA, Donehower LA, Schwartzkroin PA. Loss of the p53 tumor suppressor gene protects neurons from kainate-induced cell death. J Neurosci 1996;16:1337-45. https://doi.org/10.1523/JNEUROSCI.16-04-01337.1996
  37. Laptenko O, Prives C. Transcriptional regulation by p53: one protein, many possibilities. Cell Death Differ 2006;13:951-61. https://doi.org/10.1038/sj.cdd.4401916
  38. Brooks CL, Gu W. Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation. Curr Opin Cell Biol 2003;15:164-71. https://doi.org/10.1016/S0955-0674(03)00003-6
  39. Ashkenazi A, Pai RC, Fong S, Leung S, Lawrence DA, Marsters SA, Blackie C, Chang L, McMurtrey AE, Hebert A, et al. Safety and antitumor activity of recombinant soluble Apo2 ligand. J Clin Invest 1999;104:155-62. https://doi.org/10.1172/JCI6926
  40. Armeanu S, Lauer UM, Smirnow I, Schenk M, Weiss TS, Gregor M, Bitzer M. Adenoviral gene transfer of tumor necrosis factor-related apoptosis-inducing ligand overcomes an impaired response of hepatoma cells but causes severe apoptosis in primary human hepatocytes. Cancer Res 2003;63:2369-72.
  41. Lemasters JJ, Nieminen AL, Qian T, Trost LC, Elmore SP, Nishimura Y, Crowe RA, Cascio WE, Bradham CA, Brenner DA, et al. The mitochondrial permeability transition in cell death: a common mechanism in necrosis, apoptosis and autophagy. Biochim Biophys Acta 1998;1366(1-2):177-96. https://doi.org/10.1016/S0005-2728(98)00112-1
  42. Shang XJ, Yao G, Ge JP, Sun Y, Teng WH, Huang YF. Procyanidin induces apoptosis and necrosis of prostate cancer cell line PC-3 in a mitochondriondependent manner. J Androl 2009;30:122-6.
  43. Nam KY, Choi JE, Park JD. Transformation Techniques for the Large Scale Production of Ginsenoside Rg3. Korean J Medicinal Crop Sci 2013;21(5):401-14. https://doi.org/10.7783/KJMCS.2013.21.5.401

Cited by

  1. Dissipation rates and residues of fungicide azoxystrobin in ginseng and soil at two different cultivated regions in China vol.188, pp.7, 2015, https://doi.org/10.1007/s10661-016-5449-2
  2. Ginsenoside Rg5 Ameliorates Cisplatin-Induced Nephrotoxicity in Mice through Inhibition of Inflammation, Oxidative Stress, and Apoptosis vol.8, pp.9, 2016, https://doi.org/10.3390/nu8090566
  3. Black Ginseng Extract Counteracts Streptozotocin-Induced Diabetes in Mice vol.11, pp.1, 2016, https://doi.org/10.1371/journal.pone.0146843
  4. 흑삼의 프로사포게닌 추출물이 Streptozotocin으로 유도된 당뇨 쥐에 대한 항당뇨 효과 및 신장보호 효과 vol.24, pp.2, 2015, https://doi.org/10.7783/kjmcs.2016.24.2.115
  5. Plant Resources, 13 C-NMR Spectral Characteristic and Pharmacological Activities of Dammarane-Type Triterpenoids vol.21, pp.8, 2016, https://doi.org/10.3390/molecules21081047
  6. 원료삼 크기와 형태가 흑삼의 품질에 미치는 영향 vol.29, pp.5, 2016, https://doi.org/10.9799/ksfan.2016.29.5.610
  7. Inhibitory Effect of Ginseng on Breast Cancer Cell Line Growth Via Up-Regulation of Cyclin Dependent Kinase Inhibitor, p21 and p53 vol.17, pp.11, 2015, https://doi.org/10.22034/apjcp.2016.17.11.4965
  8. Anticancer effects of ginsenoside Rk3 on non-small cell lung cancer cells: in vitro and in vivo vol.8, pp.10, 2015, https://doi.org/10.1039/c7fo00385d
  9. Raphanus sativus Sprout Causes Selective Cytotoxic Effect on p53-Deficient Human Lung Cancer Cells in vitro vol.12, pp.2, 2017, https://doi.org/10.1177/1934578x1701200224
  10. Caspase-Mediated Anti-Apoptotic Effect of Ginsenoside Rg5, a Main Rare Ginsenoside, on Acetaminophen-Induced Hepatotoxicity in Mice vol.65, pp.42, 2015, https://doi.org/10.1021/acs.jafc.7b03361
  11. Mechanistic evaluation of phytochemicals in breast cancer remedy: current understanding and future perspectives vol.8, pp.52, 2015, https://doi.org/10.1039/c8ra04879g
  12. Synergistic effect of combined protopanaxatiol and ginsenoside Rh2 on antiproliferative activity in MDA-MB-231 human breast cancer cells in vitro vol.29, pp.1, 2015, https://doi.org/10.1080/09540105.2018.1490700
  13. Determination of the transformation of ginsenosides in Ginseng Radix et Rhizoma during decoction with water using ultra‐fast liquid chromatography coupled with tandem mass spectrometry vol.41, pp.5, 2015, https://doi.org/10.1002/jssc.201701228
  14. Sesquiterpenoids from the root of Panax Ginseng protect CCl4–induced acute liver injury by anti-inflammatory and anti-oxidative capabilities in mice vol.102, pp.None, 2015, https://doi.org/10.1016/j.biopha.2018.02.041
  15. UPLC-QTOF/MS-Based Metabolomics Applied for the Quality Evaluation of Four Processed Panax ginseng Products vol.23, pp.8, 2015, https://doi.org/10.3390/molecules23082062
  16. In Vitro/In Vivo Metabolism of Ginsenoside Rg5 in Rat Using Ultra-Performance Liquid Chromatography/Quadrupole-Time-of-Flight Mass Spectrometry vol.23, pp.9, 2015, https://doi.org/10.3390/molecules23092113
  17. Antiproliferative Activity of Combined Biochanin A and Ginsenoside Rh 2 on MDA-MB-231 and MCF-7 Human Breast Cancer Cells vol.23, pp.11, 2015, https://doi.org/10.3390/molecules23112908
  18. Ginsenoside Rg5 induces apoptosis and autophagy via the inhibition of the PI3K/Akt pathway against breast cancer in a mouse model vol.9, pp.11, 2018, https://doi.org/10.1039/c8fo01122b
  19. Recent Advances of Novel Therapeutic Agents from Botanicals for Prevention and Therapy of Breast Cancer: An Updated Review vol.15, pp.None, 2015, https://doi.org/10.2174/1573394715666181129101502
  20. Comparative analysis of active ingredients and effects of the combination of Panax ginseng and Ophiopogon japonicus at different proportions on chemotherapy-induced myelosuppression mouse vol.10, pp.3, 2015, https://doi.org/10.1039/c8fo02354a
  21. Ginsenoside Rg5 induces apoptosis in human esophageal cancer cells through the phosphoinositide-3 kinase/protein kinase B signaling pathway vol.19, pp.5, 2019, https://doi.org/10.3892/mmr.2019.10093
  22. Black Ginseng and Its Saponins: Preparation, Phytochemistry and Pharmacological Effects vol.24, pp.10, 2015, https://doi.org/10.3390/molecules24101856
  23. Ginseng: A Qualitative Review of Benefits for Palliative Clinicians vol.36, pp.7, 2015, https://doi.org/10.1177/1049909118822704
  24. Inhibitory Effects of Ginsenoside Ro on the Growth of B16F10 Melanoma via Its Metabolites vol.24, pp.16, 2019, https://doi.org/10.3390/molecules24162985
  25. Recent Advances in Ginsenosides as Potential Therapeutics Against Breast Cancer vol.19, pp.25, 2015, https://doi.org/10.2174/1568026619666191018100848
  26. Black Ginseng and Ginsenoside Rb1 Promote Browning by Inducing UCP1 Expression in 3T3-L1 and Primary White Adipocytes vol.11, pp.11, 2015, https://doi.org/10.3390/nu11112747
  27. Suppression of FADS1 induces ROS generation, cell cycle arrest, and apoptosis in melanocytes: implications for vitiligo vol.11, pp.24, 2015, https://doi.org/10.18632/aging.102452
  28. Ginsenoside Rk1 induces apoptosis and downregulates the expression of PD-L1 by targeting the NF-κB pathway in lung adenocarcinoma vol.11, pp.1, 2020, https://doi.org/10.1039/c9fo02166c
  29. Metabolic Changes in Serum Metabolome of Beagle Dogs Fed Black Ginseng vol.10, pp.12, 2015, https://doi.org/10.3390/metabo10120517
  30. Ginsenoside Rg5 Inhibits Human Osteosarcoma Cell Proliferation and Induces Cell Apoptosis through PI3K/Akt/mTORC1-Related LC3 Autophagy Pathway vol.2021, pp.None, 2015, https://doi.org/10.1155/2021/5040326
  31. Anticancer Activities of Ginsenosides, the Main Active Components of Ginseng vol.2021, pp.None, 2021, https://doi.org/10.1155/2021/8858006
  32. Changes of Prosapogenin Components in Tienchi Seng (Panax notoginseng) by Ultrasonic Thermal Fusion Process vol.27, pp.1, 2015, https://doi.org/10.20307/nps.2021.27.1.10
  33. An Efficient Synthesis of Ginsenoside Rg5 via Conversion of PPD Type Saponins: Unusual Application of 4A Molecular Sieves vol.16, pp.4, 2015, https://doi.org/10.1177/1934578x211007637
  34. Pharmacological activities of ginsenoside Rg5 (Review) vol.22, pp.2, 2015, https://doi.org/10.3892/etm.2021.10272
  35. Korean red ginseng induces extrinsic and intrinsic apoptotic pathways in MCF‐7 breast cancer cells and MCF‐10A non‐malignant breast cells vol.47, pp.8, 2015, https://doi.org/10.1111/jog.14826
  36. Network Pharmacology of Red Ginseng (Part I): Effects of Ginsenoside Rg5 at Physiological and Sub-Physiological Concentrations vol.14, pp.10, 2015, https://doi.org/10.3390/ph14100999
  37. Network Pharmacology of Ginseng (Part II): The Differential Effects of Red Ginseng and Ginsenoside Rg5 in Cancer and Heart Diseases as Determined by Transcriptomics vol.14, pp.10, 2015, https://doi.org/10.3390/ph14101010
  38. Anticancer activity of Nigerian medicinal plants: a review vol.7, pp.1, 2015, https://doi.org/10.1186/s43094-021-00222-6